Publication | Closed Access

Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin

MedicineCancer ManagementP53 MutationPathologyGynecologyPrognostic SignificanceAdvanced Ovarian CarcinomaCancer TreatmentOncologyTumor BiologyOvarian Cancer